RFK Jr announced 14 peptides moving out of Category 2 on Joe Rogan. The FDA advisory committee is now confirmed for July 2026. Here’s the full timeline, every peptide on the list, and what reclassification actually means.
Not all peptide vendors ship at the same speed or reliability. Here is exactly what to look for before you place an order.
Not all purity measurements are the same. HPLC, mass spectrometry, and amino acid analysis each reveal different things about a peptide — and understanding the differences helps you read a Certificate of Analysis correctly.
Starting a peptide research protocol for the first time? Here’s what to order, why each component is needed, and how to build a logical starting stack without overbuying.
Good research is reproducible research. A consistent research journal is the foundation of that reproducibility. Here’s what to record, when to record it, and a template you can use today.
Subcutaneous and intramuscular injections differ in absorption speed, volume capacity, needle size, and which peptides use each route. This guide walks through the pharmacokinetics, practical technique, and which route is typically used for which peptide class.
Not all peptides are created equal. This guide explains what purity percentages really mean, how HPLC and mass spectrometry testing works, what common impurities do to your research data, and how to read a Certificate of Analysis like a professional.
A Gila monster’s saliva led to a $100 billion drug class. Here’s the full story — from exendin-4’s discovery in 1992, to Ozempic going viral on TikTok, to retatrutide pushing weight loss past 24%. And what all of it means for the research peptide world.
Telehealth peptide clinics are charging $400–$900/month for compounded semaglutide and BPC-157. Research-grade suppliers charge a fraction of that. Here’s an honest breakdown of the two routes — cost, quality, legal framework, and who each one is actually for.
Retatrutide is in Phase 3. CagriSema is showing 22% weight loss. Oral GLP-1s are nearly here. Here’s what the peptide clinical trial pipeline looks like heading into 2027 — and what it means for research.
